Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 42 (5), 302-5

[Genes in Alzheimer's Disease]

[Article in Spanish]
Affiliations
  • PMID: 16538594
Review

[Genes in Alzheimer's Disease]

[Article in Spanish]
J Hoenicka. Rev Neurol.

Abstract

Introduction: Alzheimer's disease (AD) is the most frequent degenerative dementia among the elderly population. Families that have an autosomal dominant pattern for AD constitute about 13% of early cases (< or = 65 years) and less than 0.01% of the total number of patients.

Development: Molecular analysis of families with early onset AD has made it possible to identify mutations in three different genes that are responsible for the disease: the gene encoding for the amyloid precursor protein peptide (APP), and the presenilin 1 (PSEN1) and presenilin 2 (PSEN2) genes. Yet, these genes are involved in less than 5% of the total number of cases of AD. The remaining AD patients are mostly cases of late or familial onset, where the disease appears as a result of a complex interaction among environmental factors and individual predisposing genetic traits. A large number of molecular genetics studies have clearly implicated the APOE epsilon4 allele as a proven risk factor for the late form of AD in almost all the populations that have been studied.

Conclusions: Although the APOE epsilon4 allele is the only proven genetic risk factor for the late form of the disease, genetic epidemiological studies suggest that other loci are also involved.

Similar articles

See all similar articles

Cited by 2 articles

LinkOut - more resources

Feedback